Search Results 391-400 of 15937 for clindamycin

  1. Adalimumab-fkjp (subcutaneous route) - Mayo Clinic

    Adalimumab-fkjp injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing ...

  2. Cinacalcet (oral route) - Mayo Clinic

    Cinacalcet is used to treat hyperparathyroidism in patients with chronic kidney disease who are on dialysis. Hyperparathyroidism is a condition that is caused ...

  3. A Study to Evaluate Acalabrutinib With or Without Obinutuzumab to Treat Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

  4. Saxagliptin (oral route) - Mayo Clinic

    Saxagliptin is used with proper diet and exercise to treat high blood sugar (glucose) levels in patients with type 2 diabetes. Saxagliptin helps to control ...

  5. Prognostic Risk Evaluation for Hypereosinophilic Syndrome (HES) and Idiopathic Hypereosinophilia (IHE) and the Role of Next-generation Sequencing - Mayo Clinic

    About this study. The purpose of this study is to: To identify predictors of inferior overall survival in HES/IHE patients including molecular parameters ...

  6. Crizotinib (oral route) - Mayo Clinic

    Crizotinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer (NSCLC) that is caused by a defect in either a gene called ...

  7. Endometriosis - Diagnosis and treatment - Mayo Clinic

    Transvaginal ultrasound · Pelvic exam. Your health care professional feels areas in your pelvis with one or two gloved fingers to check for any unusual changes.

  8. Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/ ...

  9. A Biorepository to Study Portopulmonary Hypertension - Mayo Clinic

    About this study. We propose to develop a biorepository of plasma samples from patients with suspected and confirmed portopulmonary hypertension to improve ...

  10. A Study to Evaluate the Addition of Immunotherapy into Adjuvant Therapy for Non-small Cell Lung Cancer - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...